Transcatheter aortic valve implantation: 10-year anniversary. Part II: clinical implications
Author(s) -
Philippe Généreux,
Stuart J. Head,
David A. Wood,
S. K. Kodali,
Mathew Williams,
J.-M. Paradis,
Marco Spaziano,
A. Pieter Kappetein,
John Webb,
Alain Cribier,
M.B. Leon
Publication year - 2012
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1093/eurheartj/ehs223
Subject(s) - medicine , stenosis , aortic valve stenosis , aortic valve replacement , leak , cardiology , prosthesis , surgery , intensive care medicine , environmental engineering , engineering
Transcatheter aortic valve implantation (TAVI) has been increasingly recognized as a curative treatment for severe aortic stenosis (AS). Despite important improvements in current device technology and implantation techniques, specific complications still remain and warrant consideration. Vascular complications and peri-procedural neurological events were the first concerns to emerge with this new technology. Recently, significant post procedural para-valvular leak has been shown to be more frequent after TAVI than after surgical aortic valve replacement (SAVR), and its potential association with worse long-term prognostic has raised concerns. In moving toward treatment of lower risk populations, structural integrity and long-term durability of heat valve prosthesis are becoming of central importance. Emerging technologies and newer generations of devices seem promising in dealing with these matters.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom